Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...
Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...
Next-gen lip care is here.
Laura Short reveals the common mistakes and simple fixes nobody talks about when it comes to clinical photography.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results